CGG Veritas (CGV) Posts Q4 EPS of 11c; Revs Heavy

CGG Veritas (NYSE: CGV) reported Q4 EPS of $0.11, $0.25 worse than the analyst estimate of $0.36. Revenue for the quarter came in at $905.7 million versus the consensus estimate of $874 million.

For earnings history and earnings-related data on CGG Veritas (CGV) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Star Equity to acquire Harte Hanks for $5.00 per share